+61 3 9467 4966
enquiries@cyclotek.com
Menu
Home
Company
About Us
Research Philosophy
Corporate
Time Line History
Brochures
Products
Compounded Products
Product Supply
Contract Manufacturing
Quality System
Logistics
Collaborations
News
Facilities
Corporate
Melbourne – Bundoora
Brisbane – Woolloongabba
Wellington – New Zealand
Melbourne – Parkville
Sydney – Lucas Heights
Sydney – Macquarie University Hospital
News
Categories
Categories
Select Category
Clinical
Company
Latest News
Research
Uncategorized
Cyclotek lends a hand in PSMA-PET in Active Surveillance for Ca Prostate
Posted on: 09 June 2022
Research
read More
PSMA PET scans for prostate cancer will be funded through the Medical Benefits Schedule (MBS)
Posted on: 05 May 2022
Latest News
read More
Cyclotek supports Macquarie University’s Research Studies in Motor Neuron Disease (MND)
Posted on: 16 February 2022
Research
read More
Cyclotek announces the CRIB Project at Bio21
Posted on: 15 February 2022
Clinical
read More
Advanced manufacturing in Australia: Applied Molecular Therapies launches its first thernostic product in prostate cancer treatment
Posted on: 10 February 2022
Latest News
read More
A conversation with Prof. Terry O’Brien and Dr. Lucy Vivash on the future of positron emission tomography (PET) in neurology
Posted on: 10 February 2022
Uncategorized
read More
Page 4 of 10
« First
Previous
...
2
3
4
5
6
...
10
...
Next
Last »
© 2026 Cyclotek. All rights reserved
[contact-form-7 id=”714″ title=”Update Form”]
